Teaneck-based Phibro Animal Health Corporation announced Monday the pricing of its initial public offering of 11.765 million shares of common stock at a price to the public of $16.00 to $18.00 per share.According to the announcement, the stock will be offered by the company and a selling stockholder, Mayflower Limited Partnership. Mayflower plans to grant the underwriters a 30-day option to purchase up to an additional 1.764 million shares of the stock.
Bank of America Merrill Lynch, Morgan Stanley and Barclays are serving as the joing bookrunning managers for the offering. Guggenheim Securities, Macquarie Capital and Cantor Fitzgerald & Co. are acting as co-managers for the offering. Perella Weinberg Partners is acting as advisor to the company, the company said in a recent press release.
ALSO ON NJBIZ:
With April 1 deadline looming, N.J. facing surge of property tax appeals
When shouldn’t you file a property tax appeal?
In Newark, revaluation is spurring action